In new
guidelines specific to maternal-fetal medicine practitioners, published online
in the American Journal of Obstetrics & Gynecology MFM,
recommendations are presented for prenatal care in the setting of the novel
coronavirus 2019 (COVID-19) pandemic.

Rupsa C.
Boelig, M.D., from Thomas Jefferson University in Philadelphia, and colleagues
address the current COVID-19 pandemic for maternal-fetal medicine
practitioners, with the goals of reducing patient risk through health care
exposure and reducing the public health burden of COVID-19 transmission through
the general population.

The
recommendations relate to issues including modifications of outpatient
obstetrical (prenatal) visits, scheduling of obstetrical ultrasound, and
modification of non-stress tests and biophysical profiles. Elective or non-urgent
visits should be postponed; each patient should be called to decide on the need
for subsequent visits and/or tests.

New
obstetric intake should be completed remotely or by telehealth unless the
patient describes an urgent problem. Laboratory work and/or ultrasounds should
be performed at the same time as in-person visits. The routine practice of
face-to-face counseling for ultrasounds should be altered. Patients should be
instructed to obtain a blood pressure cuff if feasible to minimize other
in-patient visits.

“We
know that these recommendations won’t cover every situation,” a co-author
said in a statement. “In areas with a higher COVID-19 incidence more restrictive
measures will likely be appropriate. This guidance is changing daily, in fact
hourly. Stay tuned.”

SOURCE: https://www.practiceupdate.com/c/98201/2/6/?elsca1=emc_enews_daily-digest&elsca2=email&elsca3=practiceupdate_primary&elsca4=primary-care&elsca5=newsletter&rid=NTU2MjE4MTIzNzES1&lid=10332481

REFERENCE:
Boelig et al: MFM Guidance for COVID-19; 
https://www.sciencedirect.com/science/article/pii/S2589933320300367